Edwards Lifesciences CEO: Improving procedures for structural heart disease is 'our No. 1 focus'

Edwards Lifesciences CEO Michael Mussallem tells CNBC's Jim Cramer that the medical equipment company has prioritized improving care for structural heart disease, which develops through wear and tear. "There's so many unmet needs amongst these patients," he tells the "Mad Money" host.
07:04
Thu, Dec 5 20197:18 PM EST